血塞通联合低分子肝素钠治疗不稳定性心绞痛的临床观察.docVIP

精品论文 参考文献 血塞通联合低分子肝素钠治疗不稳定性心绞痛的临床观察 （菏泽鲁心心脑血管病医院 山东 菏泽 274000） 【摘 要】目的：观察血塞通与低分子肝素钠联合治疗不稳定性心绞痛的临床疗效及对血液流变学、 血脂的影响。方法：将所观察的124例患者随机分为治疗组(注射用血塞通与低分子肝素钠组)64 例, 对照组(阿司匹林与低分子肝素钠组) 60例, 分别治疗7d 后观察临床疗效, 14d 后观察血液流变学及血脂的变化。结果：治疗组总有效率及治疗后心绞痛发作次数、心绞痛持续时间、发作间隔时间、Holter 24h 缺血总时间等改善方面均优于对照组(Plt;0.05)。两组治疗后全血黏度(高切、低切)、血浆黏度、甘油三酯、胆固醇均较治疗前明显下降(Plt;0.05, Plt;0.01) , 其中全血高切比黏度的降低治疗组优于对照组(Plt;0.05) , 而且治疗组能明显降低患者的纤维蛋白原(Plt;0.01)。结论：注射用血塞通与低分子肝素钠联合治疗不稳定性心绞痛疗效显著,且能降低血脂、血黏度及纤维蛋白原而无出血现象发生,而且没有增加出血等并发症。 【关键词】注射用血塞通；低分子肝素钠；不稳定性心绞痛；临床疗效 【中图分类号】R541 【文献标识码】A 【文章编号】1004-6194（2015）02-0116-02 Clinical observation of panax notoginseng saponins combined with low molecular weight heparin-Na therapy for unstable angina 【Abstract】Objectives:To observe clinical curative effect of panax notoginseng saponins combined with low molecular weight heparin-Na therapy for unstable angina, and the effects on blood rheology and blood lipid.Methods:124 patients with unstable angina were randomly divided into treatment group and control group, the treatment group(64 patients)treated by panax notoginseng saponins for injection combined with low molecular weight heparin-Na,the control group(60 patients)treated by aspirin combined with low molecular weight heparin-Na.Clinical curative effect were observed respectively after 7 days treatment, and the effects on blood rheology and blood lipid were observed after 14 days treatment.Results:Treatment group was better than control group on total effective rate, attack frequency of angina pectoris, duration of angina pectoris,onset time interval,total 24 h Holter ischemia time(Plt;0.05).Significant lower of whole blood viscosity (high shear,low shear), plasma viscosity,triglyceride and cholesterol were found in the two groups (Plt;0.05,Plt;0.01).In which the whole blood high shear viscosity was lower than control group(Plt;0.05).The level of fibrinogen in treatment group was lower than control group after treatment(Plt;0.01).Conclusions:Panax notogins